Physician profile
Tejwant Bindra
NPI 1982862843
$3,341.31
in general payments reported to CMS, 2019-2025
16 companies · $1,540 in 2025
The $1,540 reported for 2025 was more than what 75% of Neurology With Special Qualifications In Child Neurology providers received nationally (typical 2025 total: $275).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $12.77 · 2022: $229 · 2023: $290 · 2024: $1,269 · 2025: $1,540.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,933 · Education: $120 · Travel and Lodging: $45.98.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,933.44 |
| Education | $119.98 |
| Travel and Lodging | $45.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Harmony Biosciences LLC | $757.61 | 2023-2025 | Wakix |
| Jazz Pharmaceuticals INC. | $721.29 | 2022-2025 | |
| Ucb, INC. | $508.03 | 2024-2025 | Fintepla, Briviact, Nayzilam |
| Itamar Medical INC | $357.82 | 2025 | Watchpatone |
| Medtronic, INC. | $193.03 | 2025 | Percept PC Brainsense, Catalyft Pl Expandable Interbody System |
| Supernus Pharmaceuticals, INC. | $147.68 | 2024-2025 | Qelbree |
| Olympus America INC. | $144.44 | 2024 | Spin Vision Video Processor |
| Inspire Medical Systems, INC. | $142.59 | 2024 | Inspire |
| Axsome Therapeutics, INC. | $118.41 | 2023 | Sunosi |
| Avadel Cns Pharmaceuticals, LLC | $89.25 | 2024 | Lumryz |
| Neurelis, INC. | $47.51 | 2025 | Valtoco |
| Corium, LLC | $34.90 | 2024-2025 | Azstarys |
| Exeltis, USA INC. | $24.59 | 2025 | Slynd |
| Millicent US INC | $23.40 | 2025 | Femlyv |
| Tris Pharma INC | $17.99 | 2025 | Dyanavel Xr |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Livanova USA, INC. | $12.77 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Tejwant Bindra listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.